01 5Belmore Neidrauer LLP
02 28Blake Cassels & Graydon LLP
01 22140929
02 32224738
03 52336160
04 12416757
05 42469343
06 62485834
07 22678907
08 22720856
09 12845553
10 72872424
01 4DARUNAVIR ETHANOLATE
02 4DARUNAVIR ETHANOLATE | COBICISTAT
03 5DARUNAVIR ETHANOLATE | COBICISTAT | EMTRICITABINE | TENOFOVIR ALAFENAMIDE HEMIFUMARATE
04 20Darunavir ethanolate
01 4SUSPENSION
02 9TABLET
03 20Tablet
01 22013-08-24
02 32016-06-28
03 122019-06-23
04 12021-07-20
05 42022-12-12
06 62023-05-16
07 22028-02-22
08 22029-05-01
09 12032-08-15
Patent Expiration Date : 2028-02-22
Date Granted : 2014-06-17
DARUNAVIR ETHANOLATE, COBICISTAT
Brand Name : PREZCOBIX
Patent Number : 2678907
Filing Date : 2008-02-22
Strength per Unit : 800 mg / 150 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-02-22
Date Granted : 2014-06-17
Patent Expiration Date : 2029-05-01
Date Granted : 2016-02-02
DARUNAVIR ETHANOLATE, COBICISTAT
Brand Name : PREZCOBIX
Patent Number : 2720856
Filing Date : 2009-05-01
Strength per Unit : 800 mg / 150 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-05-01
Date Granted : 2016-02-02
Patent Expiration Date : 2023-05-16
Date Granted : 2007-07-17
Brand Name : PREZISTA
Patent Number : 2485834
Filing Date : 2003-05-16
Strength per Unit : 600 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-05-16
Date Granted : 2007-07-17
Patent Expiration Date : 2022-12-12
Date Granted : 2008-05-13
Brand Name : PREZISTA
Patent Number : 2469343
Filing Date : 2002-12-12
Strength per Unit : 600 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-12-12
Date Granted : 2008-05-13
Patent Expiration Date : 2022-12-12
Date Granted : 2008-05-13
Brand Name : PREZISTA
Patent Number : 2469343
Filing Date : 2002-12-12
Strength per Unit : 75 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-12-12
Date Granted : 2008-05-13
Patent Expiration Date : 2023-05-16
Date Granted : 2007-07-17
Brand Name : PREZISTA
Patent Number : 2485834
Filing Date : 2003-05-16
Strength per Unit : 75 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-05-16
Date Granted : 2007-07-17
Patent Expiration Date : 2019-06-23
Date Granted : 2015-02-17
Brand Name : PREZISTA
Patent Number : 2336160
Filing Date : 1999-06-23
Strength per Unit : 600 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-06-23
Date Granted : 2015-02-17
Patent Expiration Date : 2019-06-23
Date Granted : 2015-02-17
Brand Name : PREZISTA
Patent Number : 2336160
Filing Date : 1999-06-23
Strength per Unit : 75 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-06-23
Date Granted : 2015-02-17
Patent Expiration Date : 2013-08-24
Date Granted : 2006-09-12
Brand Name : PREZISTA
Patent Number : 2140929
Filing Date : 1993-08-28
Strength per Unit : 150 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-08-24
Date Granted : 2006-09-12
Patent Expiration Date : 2016-06-28
Date Granted : 2002-08-27
Brand Name : PREZISTA
Patent Number : 2224738
Filing Date : 1996-06-28
Strength per Unit : 150 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-06-28
Date Granted : 2002-08-27
